Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument‐Short Form
Autor: | Taylor Howell, Shilpa Gummadi, Chau Bui, Jessica Santhakumar, Kristen Knight, Erik D. Roberson, Daniel Marson, Carol Chambless, Adam Gersteneker, Roy Martin, Richard Kennedy, Yue Zhang, John C. Morris, Krista L. Moulder, Connie Mayo, Maria Carroll, Yan Li, Ronald C. Petersen, Nikki H. Stricker, Rachel L. Nosheny, Scott Mackin, Michael W. Weiner |
---|---|
Rok vydání: | 2022 |
Předmět: |
Aging
Brain Health Registry Clinical Trials and Supportive Activities Neurosciences Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) Alzheimer's disease Neurodegenerative aging research Brain Disorders Psychiatry and Mental health Good Health and Well Being Clinical Research Behavioral and Social Science Neurological Acquired Cognitive Impairment Genetics remote online instruments Dementia internet Neurology (clinical) |
Zdroj: | Alzheimer's & dementia (Amsterdam, Netherlands), vol 14, iss 1 |
ISSN: | 2352-8729 |
DOI: | 10.1002/dad2.12331 |
Popis: | IntroductionTo address the need for remote assessments of cognitive decline and dementia, we developed and administered electronic versions of the Clinical Dementia Rating (CDR®) and the Financial Capacity Instrument-Short Form (FCI-SF) (F-CAP®), called the eCDR and eFCI, respectively.MethodsThe CDR and FCI-SF were adapted for remote, unsupervised, online use based on item response analysis of the standard instruments. Participants completed the eCDR and eFCI first in clinic, and then at home within 2 weeks.ResultsOf the 243 enrolled participants, 179 (73%) cognitively unimpaired (CU), 50 (21%) with mild cognitive impairment (MCI) or dementia, and 14 (6%) with an unknown diagnosis, 84% and 85% of them successfully completed the eCDR and eFCI, respectively, at home.DiscussionThese results show initial feasibility in developing and administering online instruments to remotely assess and monitor cognitive decline along the CU to MCI/very mild dementia continuum. Validation is an important next step. |
Databáze: | OpenAIRE |
Externí odkaz: |